Improve International Ltd. has been acquired by RJD Partners
June 2020 — Benchmark Holdings Plc. has sold Improve International Ltd. to RJD Partners.
Improve International provides both specialist postgraduate courses and qualifications as well as continuing professional development training to veterinary professionals. Its key programs are structured on a modular basis comprising both face-to-face practical and classroom learning as well as online delivery. With offices in the UK and Portugal, the business has global operations across the US, Australia and Japan. Courses are also available in multiple languages.
Founded in 2000, RJD Parters is an equity investor specializing in buy-outs, buy-ins and development capital for deals worth up to US$60 million.
Benchmark Holdings develops products and solutions in genetics, health and nutrition that improve performance, animal health and welfare, and reduce environmental impact across the aquaculture production cycle.
Our role in the transaction
Oaklins Cavendish, based in the UK, advised the seller on this transaction.
James Banfield
Head of Knowledge Services, Benchmark Holdings Plc.
Contáctese con el equipo de la transacción
Transacciones relacionadas
Cibus has acquired Aweta from Standard Investment
Standard Investment has reached an agreement with Cibus Capital, advisor to the Cibus funds, on the sale of Aweta, a global leader in fruit and vegetable sorting, grading and packing equipment. Completion of the transaction is expected in the coming weeks. The transaction provides Aweta with a strong partner to support the company’s next growth phase. Under Cibus’ ownership, Aweta will pursue further international growth and accelerate investment in R&D, supporting the installed base and product innovation, including software and AI capabilities. Aweta’s leadership team will continue to lead the business.
Conozca másKatalyst Diagnostics has been acquired by Cruinn Diagnostics
Katalyst Diagnostics Ltd. has been acquired by Cruinn Diagnostics Ltd. The acquisition strengthens Cruinn Diagnostics’ presence in the UK diagnostics market, adding established NHS customer relationships, local commercial infrastructure and a complementary portfolio of point-of-care diagnostic solutions. It also creates opportunities to introduce Cruinn Diagnostics’ products to UK customers while leveraging its established Irish platform to accelerate the growth of Katalyst Diagnostics’ portfolio in Ireland. With more than 100 employees and revenues in excess of US$56 million, the combined business will continue to focus on the UK market, where Cruinn Diagnostics sees significant opportunities to expand through further investment and targeted M&A.
Conozca másGroGlass has been acquired by Apogee Enterprises
Apogee Enterprises, Inc. (Nasdaq: APOG), a leading US provider of architectural building products, services and high-performance coated materials, has acquired GroGlass, a Latvia-based developer and manufacturer of high-performance anti-reflective and UV-protective glass coatings. The acquisition brings GroGlass’ differentiated coating technologies and materials science expertise into Apogee’s performance surfaces segment, broadening its product offering and market reach while expanding its manufacturing and R&D presence in Europe.
Conozca más